Notify me when Flagship Ventures Fund V, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OMGAQ | OMEGA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 53% | $1,461,279 | 29,225,579 | Noubar Afeyan | 29 Dec 2024 | ||
| FHTX | FOGHORN THERAPEUTICS INC. | Common Stock, $0.0001 par value per share | 27% | $112,196,844 | 20,774,885 | Noubar Afeyan | 09 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|